CN114948816A - A kind of sunscreen and anti-photoaging traditional Chinese medicine composition and application thereof - Google Patents
A kind of sunscreen and anti-photoaging traditional Chinese medicine composition and application thereof Download PDFInfo
- Publication number
- CN114948816A CN114948816A CN202210649612.8A CN202210649612A CN114948816A CN 114948816 A CN114948816 A CN 114948816A CN 202210649612 A CN202210649612 A CN 202210649612A CN 114948816 A CN114948816 A CN 114948816A
- Authority
- CN
- China
- Prior art keywords
- photoaging
- chinese medicine
- traditional chinese
- medicine composition
- sun
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010051246 Photodermatosis Diseases 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- 239000003814 drug Substances 0.000 title claims abstract description 51
- 230000000475 sunscreen effect Effects 0.000 title claims description 40
- 239000000516 sunscreening agent Substances 0.000 title claims description 40
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000000284 extract Substances 0.000 claims abstract description 28
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000012153 distilled water Substances 0.000 claims abstract description 14
- 241000245032 Trillium Species 0.000 claims abstract description 13
- 238000010992 reflux Methods 0.000 claims abstract description 12
- 239000002537 cosmetic Substances 0.000 claims abstract description 11
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 9
- 240000001972 Gardenia jasminoides Species 0.000 claims abstract description 4
- 238000012216 screening Methods 0.000 claims abstract 12
- 241000904513 Hibiscus taiwanensis Species 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- 241000218033 Hibiscus Species 0.000 claims description 10
- 235000005206 Hibiscus Nutrition 0.000 claims description 10
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000006188 syrup Substances 0.000 claims description 4
- 235000020357 syrup Nutrition 0.000 claims description 4
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 238000005325 percolation Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 238000002390 rotary evaporation Methods 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 244000111489 Gardenia augusta Species 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 2
- 238000007873 sieving Methods 0.000 claims 2
- 238000000605 extraction Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 230000037303 wrinkles Effects 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 20
- 230000008845 photoaging Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241000157835 Gardenia Species 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000003642 reactive oxygen metabolite Substances 0.000 description 6
- 206010018910 Haemolysis Diseases 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000008588 hemolysis Effects 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 102000012422 Collagen Type I Human genes 0.000 description 3
- 108010022452 Collagen Type I Proteins 0.000 description 3
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 3
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 3
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 3
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 108010087230 Sincalide Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000010609 cell counting kit-8 assay Methods 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000007760 free radical scavenging Effects 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 230000005778 DNA damage Effects 0.000 description 2
- 231100000277 DNA damage Toxicity 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000003810 hyperpigmentation Effects 0.000 description 2
- 208000000069 hyperpigmentation Diseases 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006909 anti-apoptosis Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940096422 collagen type i Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明属于化妆品技术领域,具体涉及一种防晒抗光老化中药组合物及其应用。The invention belongs to the technical field of cosmetics, and in particular relates to a sunscreen and anti-photoaging traditional Chinese medicine composition and application thereof.
背景技术Background technique
皮肤老化是一个复杂的生物学过程,分为内源性老化和外源性老化两种类型。内源性老化是随时间推移而发生的皮肤老化,存在基因依赖性。外源性老化是由外界环境因素引起,其中UV辐射为主要因素,占外界影响的80%,因此外源性老化又被称为光老化。Skin aging is a complex biological process, which can be divided into two types: endogenous aging and exogenous aging. Endogenous aging is skin aging that occurs over time and is genetically dependent. Exogenous aging is caused by external environmental factors, among which UV radiation is the main factor, accounting for 80% of the external influence, so exogenous aging is also called photoaging.
光老化最为显著的临床特征是皮肤干燥、松弛结节、细纹增多、弹性下降以及色斑沉着。组织学上,光老化皮肤的黑色素细胞增多,色素过度沉着,朗格汉斯细胞明显减少,真皮层增厚,胶原蛋白纤维的显著减少,但弹性纤维却大量增多变性。细胞水平光老化的特征主要表现为活性氧自由基(ROS)的过度蓄积以及细胞外基质成分的改变。The most striking clinical features of photoaging are dry skin, saggy nodules, increased fine lines, loss of elasticity, and hyperpigmentation. Histologically, the photoaging skin has increased melanocytes, hyperpigmentation, marked reduction of Langerhans cells, thickened dermis, marked reduction of collagen fibers, but a large increase in elastic fibers and degeneration. Photoaging at the cellular level is mainly characterized by excessive accumulation of reactive oxygen species (ROS) and changes in extracellular matrix components.
研究发现80%~90%的皮肤老化由外源性因素引起,其中UV辐射是加速皮肤衰老的最主要原因。皮肤光老化涉及多种信号分子和多条信号转导通路,其分子机制主要包括DNA损伤、氧化应激、炎症反应、胶原结构改变以及细胞凋亡,UV诱导的光老化机制见开放科学(资源服务)标识码(OSID)。中药中含有丰富的蛋白质和各种氨基酸、脂类、多糖类、黄酮类、维生素、有机酸、生物碱、皂苷等营养物质,其作用机制有修复DNA损伤、抗氧化、抗炎、修复皮肤屏障功能和抗凋亡等,中药在防治和延缓皮肤光老化中起重要作用。Studies have found that 80% to 90% of skin aging is caused by exogenous factors, among which UV radiation is the main reason for accelerating skin aging. Skin photoaging involves a variety of signal molecules and multiple signal transduction pathways. The molecular mechanisms mainly include DNA damage, oxidative stress, inflammatory response, collagen structure changes and apoptosis. The mechanism of UV-induced photoaging can be found in Open Science (source). Service) Identification Code (OSID). Traditional Chinese medicine is rich in protein and various amino acids, lipids, polysaccharides, flavonoids, vitamins, organic acids, alkaloids, saponins and other nutrients. Its mechanism of action includes repairing DNA damage, anti-oxidation, anti-inflammatory, and skin repair Barrier function and anti-apoptosis, Chinese medicine plays an important role in preventing and delaying skin photoaging.
发明内容SUMMARY OF THE INVENTION
本发明目的在于提供一种防晒抗光老化中药组合物。The purpose of the present invention is to provide a sunscreen and anti-photoaging traditional Chinese medicine composition.
本发明的另一目的在于提供上述防晒抗光老化中药组合物的应用。Another object of the present invention is to provide the application of the above sunscreen and anti-photoaging traditional Chinese medicine composition.
本发明的技术方案如下:The technical scheme of the present invention is as follows:
一种防晒抗光老化中药组合物,由有效成分和DMSO组成,其中,有效成分由台湾山芙蓉甲醇回流提取物、延龄草95%乙醇提取物和栀子蒸馏水提取物以4∶3∶3的质量比组成,有效成分在DMSO中的浓度为4-8mg/mL。A sunscreen and anti-photoaging traditional Chinese medicine composition is composed of active ingredients and DMSO, wherein the active ingredients are the methanol reflux extract of Taiwan hibiscus, the 95% ethanol extract of Trillium, and the distilled water extract of Gardenia in a ratio of 4:3:3 The composition of the mass ratio, the concentration of active ingredients in DMSO is 4-8mg/mL.
在本发明的一个优选实施方案中,所述台湾山芙蓉甲醇回流提取物的制备方法包括:取风干的台湾山芙蓉的根茎研磨成粉末,用甲醇回流提取,再经减压浓缩合并萃取物,得到深棕色糖浆,浓缩之后得到膏状物,即为所述台湾山芙蓉甲醇回流提取物。In a preferred embodiment of the present invention, the preparation method of the methanol reflux extract of Hibiscus taiwana includes: taking air-dried rhizomes of Hibiscus taiwana and grinding into powder, extracting with methanol under reflux, and then concentrating under reduced pressure to combine the extracts, A dark brown syrup is obtained, and after concentration, a paste is obtained, which is the methanol reflux extract of Taiwan hibiscus.
在本发明的一个优选实施方案中,所述延龄草95%乙醇提取物的制备方法包括:取延龄草的块根于恒温烘箱中干燥,用中药粉碎机粉碎后过60目筛,用95%乙醇充分浸泡,利用多用强制渗漉罐提取,反复多次,减压浓缩提取液,冷冻干燥,得到所述延龄草95%乙醇提取物。In a preferred embodiment of the present invention, the preparation method of the trillium 95% ethanol extract comprises: taking the roots of the trillium, drying in a constant temperature oven, pulverizing with a traditional Chinese medicine pulverizer and passing through a 60-mesh sieve, and using a 95 % ethanol is fully soaked, extracted by a multi-purpose forced percolation tank, repeated several times, the extract is concentrated under reduced pressure, and freeze-dried to obtain the trillium 95% ethanol extract.
在本发明的一个优选实施方案中,所述栀子蒸馏水提取物的制备方法包括:准确称取干栀子果实粉,过60目筛,将过筛粉溶于蒸馏水,搅拌后进行冷凝蒸发,收集液体并过滤,得第一滤液;将该第一滤液重复离心收集上清液;将该上清液进行抽滤并保留第二滤液,该第二滤液于65-75℃进行旋转蒸发,得黏稠液;将该粘稠液进行冷冻干燥,得干粉,即为所述栀子蒸馏水提取物。In a preferred embodiment of the present invention, the preparation method of the Gardenia jasminoides distilled water extract comprises: accurately weighing the dried gardenia fruit powder, passing through a 60-mesh sieve, dissolving the sieved powder in distilled water, and performing condensation and evaporation after stirring, The liquid is collected and filtered to obtain the first filtrate; the first filtrate is repeatedly centrifuged to collect the supernatant; the supernatant is subjected to suction filtration and the second filtrate is retained, and the second filtrate is subjected to rotary evaporation at 65-75 ° C to obtain viscous liquid; freeze-dry the viscous liquid to obtain dry powder, which is the gardenia distilled water extract.
上述防晒抗光老化中药组合物在制备化妆品中的应用。Application of the above sunscreen and anti-photoaging traditional Chinese medicine composition in the preparation of cosmetics.
在本发明的一个优选实施方案中,所述防晒抗光老化中药组合物在所述化妆品中的含量为0.05-10wt%。In a preferred embodiment of the present invention, the content of the sunscreen and anti-photoaging traditional Chinese medicine composition in the cosmetic is 0.05-10 wt%.
进一步优选的,所述防晒抗光老化中药组合物在所述化妆品中的含量为0.1-10wt%。Further preferably, the content of the sunscreen and anti-photoaging traditional Chinese medicine composition in the cosmetic is 0.1-10wt%.
一种化妆品,含有上述防晒抗光老化中药组合物。A cosmetic comprising the above sunscreen and anti-photoaging traditional Chinese medicine composition.
在本发明的一个优选实施方案中,所述防晒抗光老化中药组合物的含量为0.05-10wt%。In a preferred embodiment of the present invention, the content of the sunscreen and anti-photoaging traditional Chinese medicine composition is 0.05-10 wt%.
进一步优选的,所述防晒抗光老化中药组合物的含量为0.1-10wt%。Further preferably, the content of the sunscreen and anti-photoaging traditional Chinese medicine composition is 0.1-10wt%.
本发明的有益效果是:The beneficial effects of the present invention are:
1、本发明具有具防晒和抗光老化功效,可用于化妆品中,达到防晒和抗衰老的效果,尤其适用于太阳光照射导致的皮肤粗糙、皱纹增多、萎黄等。1. The present invention has sunscreen and anti-photoaging effects, and can be used in cosmetics to achieve sunscreen and anti-aging effects, and is especially suitable for rough skin, increased wrinkles, chlorosis, etc. caused by sunlight.
2、本发明纯天然、无刺激、安全无毒副作用。2. The present invention is pure natural, non-stimulating, safe and non-toxic and side effects.
附图说明Description of drawings
图1为本发明实施例5中防晒抗光老化中药组合物清除DPPH自由基能力的检测结果图。1 is a graph showing the detection results of the ability of the sunscreen and anti-photoaging traditional Chinese medicine composition to scavenge DPPH free radicals in Example 5 of the present invention.
图2为本发明实施例5中防晒抗光老化中药组合物对HaCaT细胞毒性检测结果图。2 is a graph showing the results of the detection of the cytotoxicity of the sunscreen and anti-photoaging traditional Chinese medicine composition on HaCaT in Example 5 of the present invention.
图3为本发明实施例5中防晒抗光老化中药组合物对UVB诱导的HaCaT细胞损伤修复活性检测结果图。3 is a graph showing the detection results of the sunscreen and anti-photoaging traditional Chinese medicine composition in Example 5 of the present invention on the damage and repair activity of UVB-induced HaCaT cells.
图4为本发明实施例5中防晒抗光老化中药组合物对光老化HaCaT细胞中ROS含量的影响结果图。4 is a graph showing the effect of the sunscreen and anti-photoaging traditional Chinese medicine composition in Example 5 of the present invention on the ROS content in photoaging HaCaT cells.
图5为本发明实施例5中防晒抗光老化中药组合物对HaCaT细胞中I型胶原蛋白、MMP1和TIMP1的mRNA水平的影响结果图。Figure 5 is a graph showing the effect of the sunscreen and anti-photoaging traditional Chinese medicine composition in Example 5 of the present invention on the mRNA levels of type I collagen, MMP1 and TIMP1 in HaCaT cells.
图6为本发明实施例5中防晒抗光老化中药组合物在不同浓度下对红细胞中血红蛋白溶血率的影响结果图。6 is a graph showing the effect of the sunscreen and anti-photoaging traditional Chinese medicine composition at different concentrations on the hemolysis rate of hemoglobin in red blood cells in Example 5 of the present invention.
具体实施方式Detailed ways
以下通过具体实施方式结合附图对本发明的技术方案进行进一步的说明和描述。The technical solutions of the present invention will be further illustrated and described below through specific embodiments in conjunction with the accompanying drawings.
实施例1台湾山芙蓉甲醇回流提取物制备Example 1 Preparation of the methanol reflux extract of Hibiscus Taiwan
取风干的台湾山芙蓉根茎(20kg)研磨成粉末,用甲醇回流提取6次。减压浓缩合并萃取物,得到深棕色糖浆(850g),浓缩之后得到膏状物(400g)。The air-dried rhizomes (20kg) of Taiwan hibiscus were ground into powder and extracted 6 times with methanol under reflux. The combined extracts were concentrated under reduced pressure to give a dark brown syrup (850 g) which after concentration gave a paste (400 g).
实施例2延龄草95%乙醇提取物制备Example 2 Preparation of Trillium 95% ethanol extract
取延龄草块根(6.4kg)于48℃恒温烘箱中干燥,用中药粉碎机粉碎后过60目筛,用95%乙醇浸泡数h后,利用多用强制渗漉罐提取,反复多次,减压浓缩提取液,冷冻干燥,得到延龄草乙醇提取物(2.4kg)。Trillium tubers (6.4kg) were taken and dried in a constant temperature oven at 48°C, pulverized with a traditional Chinese medicine pulverizer and passed through a 60-mesh sieve, soaked in 95% ethanol for several hours, and extracted using a multi-purpose forced percolation tank. The extract was concentrated under pressure and freeze-dried to obtain an ethanolic trillium extract (2.4 kg).
实施例3栀子蒸馏水提取物制备Example 3 Preparation of Gardenia Distilled Water Extract
准确称取干栀子果实粉200g,用0.6mm筛子过筛,称取5g过筛粉溶于250mL蒸馏水,搅拌10min,然后冷凝蒸发2h,收集液体并过滤。滤液在3000r/min的条件下离心10min,收集上清液,重复离心2次;将上清液进行抽滤并保留滤液,滤液于温度70℃的旋转蒸发仪中蒸发30min,得黏稠液,放入玻璃平皿中,-20℃冰箱预冻过夜,然后冷冻干燥24h,研钵研磨成粉末状,得干粉(2g)。Accurately weigh 200g of dried gardenia fruit powder, sieve it with a 0.6mm sieve, weigh 5g of the sieved powder and dissolve it in 250mL of distilled water, stir for 10min, then condense and evaporate for 2h, collect the liquid and filter. The filtrate was centrifuged at 3000r/min for 10min, the supernatant was collected, and the centrifugation was repeated twice; the supernatant was suction filtered and the filtrate was retained, and the filtrate was evaporated in a rotary evaporator at a temperature of 70°C for 30min to obtain a viscous liquid, which was put Put it into a glass plate, pre-freeze it in a -20°C refrigerator overnight, then freeze-dry it for 24 hours, and grind it into powder with a mortar to obtain dry powder (2 g).
实施例4防晒抗光老化中药组合物制备Example 4 Preparation of sunscreen and anti-photoaging traditional Chinese medicine composition
按照质量比例为4∶3∶3,分别取实施例1、2、3制备的台湾山芙蓉甲醇回流提取物、延龄草95%乙醇提取物和栀子蒸馏水提取混合均匀组成有效成分,加入DMSO充分溶解,使有效成分的终浓度为5mg/mL,得到防晒抗光老化中药组合物。According to the mass ratio of 4:3:3, take the methanol reflux extract of Taiwan hibiscus, 95% ethanol extract of Trillium and gardenia distilled water prepared in Examples 1, 2 and 3, respectively, extract and mix to form the active ingredients, add DMSO It is fully dissolved so that the final concentration of the active ingredient is 5 mg/mL, and the sunscreen and anti-photoaging traditional Chinese medicine composition is obtained.
实施例5防晒抗光老化中药组合物效果实验Example 5 Effect experiment of sunscreen and anti-photoaging traditional Chinese medicine composition
A清除DPPH自由基能力的研究Study on the ability of A to scavenge DPPH free radicals
使用DPPH自由基清除能力检测试剂盒(碧云天,BC4750)检测多肽清除自由基的活性。取500μL试剂二溶液,冰上解冻后,加入试剂一溶液(无水乙醇)2625μL,充分混匀,置于冰上待用。取ImL试剂盒提供的提取液加入到试剂三的棕色玻璃管中,充分混匀后,分装保存50μL每管,置于-20℃;从-20℃冰箱中取出防晒抗光老化中药组合物储存液,加入DMSO稀释,置于冰上待用同时准备溶剂备用。分光光度计预热30min以上,调节波长至515nm,无水乙醇调零。将10mg/mL维生素C溶液(试剂三)用提取液配制成大于0.3mg/mL的维生素C溶液待用(向储存离心管加入1.2mL的提取液,充分混匀)。在1.5mLEP管中分别加入防晒抗光老化中药组合物溶液、DMSO、提取液以及工作液,使防晒抗光老化中药组合物终浓度为62.5μM、125μM、250μM、500μM、1000μM。混匀后室温避光静置30min,于515nm处的吸光度。空白管、阳性对照管、对照管和测定管的吸光值分别记为A空白、A阳性对照、A对照和A测定。空白管只需测1-2次。仪器开机预热,调试参数。使用仪器进行检测,记录检测数据并分析得出结果如图1所示,防晒抗光老化中药组合物具有较强的自由基清除活性,并且具有浓度依赖性。The free radical scavenging activity of peptides was detected by using DPPH free radical scavenging ability detection kit (Biyuntian, BC4750). Take 500 μL of the second reagent solution, thaw on ice, add 2625 μL of the first reagent solution (absolute ethanol), mix well, and put it on ice for use. Get the extract provided by the 1mL test kit and add it to the brown glass tube of Reagent 3. After fully mixing, store 50 μL of each tube in aliquots and place at -20°C; Take out the sunscreen and anti-photoaging Chinese medicine composition from the -20°C refrigerator. Stock solution, add DMSO to dilute, put on ice for use and prepare solvent for future use. Preheat the spectrophotometer for more than 30min, adjust the wavelength to 515nm, and zero in anhydrous ethanol. The 10 mg/mL vitamin C solution (reagent 3) was prepared into a vitamin C solution greater than 0.3 mg/mL with the extract for use (add 1.2 mL of the extract to the storage centrifuge tube and mix well). The sunscreen and anti-photoaging traditional Chinese medicine composition solution, DMSO, extract and working solution were added to the 1.5mL EP tube respectively, so that the final concentrations of the sunscreen and anti-photoaging traditional Chinese medicine composition were 62.5 μM, 125 μM, 250 μM, 500 μM and 1000 μM. After mixing, let it stand for 30min at room temperature in the dark, and the absorbance at 515nm. The absorbance values of blank tube, positive control tube, control tube and assay tube were recorded as A blank, A positive control, A control and A determination, respectively. The blank tube only needs to be tested 1-2 times. The instrument is turned on to warm up and adjust the parameters. The instrument was used for detection, the detection data were recorded and analyzed, and the results were obtained as shown in Figure 1. The sunscreen and anti-photoaging traditional Chinese medicine composition has strong free radical scavenging activity and is concentration-dependent.
B CCK-8法检测防晒抗光老化中药组合物对HaCaT的细胞毒性Determination of cytotoxicity of sunscreen and anti-photoaging traditional Chinese medicine composition on HaCaT by B CCK-8 method
将HaCaT细胞种植到96孔板(约4×104/孔),24h细胞完全贴壁后,去除培养基,加入含不同浓度的防晒抗光老化中药组合物的100μL无血清培养基,24h后,向96孔板加入10μL的CCK-8试剂,2h后,在450nm的波长下,检测OD值。结果如图2所示,防晒抗光老化中药组合物在浓度为0~40μg/mL时对HaCaT细胞无毒性,当其浓度达到80μg/mL时,表现出微弱的细胞毒性。HaCaT cells were seeded into a 96-well plate (about 4×10 4 /well), and after 24 hours, the cells were completely adherent, the medium was removed, and 100 μL of serum-free medium containing different concentrations of sunscreen and anti-photoaging Chinese medicine compositions was added, and after 24 hours , 10 μL of CCK-8 reagent was added to the 96-well plate, and after 2 h, the OD value was detected at a wavelength of 450 nm. The results are shown in Figure 2. The sunscreen and anti-photoaging Chinese medicine composition has no toxicity to HaCaT cells when the concentration is 0-40 μg/mL, and shows weak cytotoxicity when the concentration reaches 80 μg/mL.
C防晒抗光老化中药组合物对UVB诱导的HaCaT细胞损伤修复活性检测Detection of sunscreen and anti-photoaging traditional Chinese medicine composition on UVB-induced damage and repair of HaCaT cells
将HaCaT细胞种植到96孔板(约4×104/孔),24h细胞完全贴壁后,去除培养基,加入含不同浓度的防晒抗光老化中药组合物的100μL无血清培养基预处理24h,之后用PBS洗3遍,采用UVB紫外辐照仪对HaCaT细胞进行一定辐照剂量辐照细胞。HaCaT细胞辐照后,更换1%FBS的新鲜培养基,24h后,向96孔板加入10μL的CCK-8试剂,2h后,在450nm的波长下,检测OD值。结果如图3所示,可以看到,防晒抗光老化中药组合物在浓度为0~40μg/mL时对HaCaT细胞受到的光损伤具有显著的保护作用,当其浓度为80μg/mL时保护作用减弱。HaCaT cells were seeded into a 96-well plate (about 4×10 4 /well), and after 24 hours, the cells were completely adhered, the medium was removed, and 100 μL of serum-free medium containing different concentrations of sunscreen and anti-photoaging Chinese medicine compositions was added for pretreatment for 24 hours. , and then washed 3 times with PBS, and irradiated the HaCaT cells with a certain irradiation dose using a UVB ultraviolet irradiator. After the HaCaT cells were irradiated, the fresh medium with 1% FBS was replaced. After 24 hours, 10 μL of CCK-8 reagent was added to the 96-well plate. After 2 hours, the OD value was detected at a wavelength of 450 nm. The results are shown in Figure 3. It can be seen that the sunscreen and anti-photoaging traditional Chinese medicine composition has a significant protective effect on the photodamage of HaCaT cells when the concentration is 0-40 μg/mL, and the protective effect is when the concentration is 80 μg/mL. weaken.
D防晒抗光老化中药组合物对光老化HaCaT细胞中ROS含量的影响DEffect of sunscreen and anti-photoaging traditional Chinese medicine composition on ROS content in photoaging HaCaT cells
使用DCFH2-DA通过荧光显微镜测定UVB辐射后HaCaT细胞内ROS的产生。首先,HaCaT细胞(1.5×105/孔)在补充有10%FBS的培养基中培养。然后,当达到80%细胞密度时更换新鲜的培养基。一定浓度的防晒抗光老化中药组合物预处理和UVB照射后,用PBS洗涤细胞,与10μM DCFH2-DA在PBS中37℃孵育30min,然后用PBS缓冲液洗涤。最后,在485nm激发和535nm发射记录分光光度计下测量荧光,结果如图4所示,防晒抗光老化中药组合物在浓度为0~40μg/mL时能够显著降低光老化HaCaT细胞中ROS的含量。The production of ROS in HaCaT cells after UVB irradiation was determined by fluorescence microscopy using DCFH2-DA. First, HaCaT cells ( 1.5 x 105/well) were cultured in medium supplemented with 10% FBS. Then, fresh medium was replaced when 80% cell density was reached. After pretreatment with a certain concentration of sunscreen and anti-photoaging Chinese medicine composition and UVB irradiation, cells were washed with PBS, incubated with 10 μM DCFH2-DA in PBS at 37°C for 30 min, and then washed with PBS buffer. Finally, fluorescence was measured under 485nm excitation and 535nm emission recording spectrophotometer. The results are shown in Figure 4. The sunscreen and anti-photoaging traditional Chinese medicine composition can significantly reduce the content of ROS in photoaging HaCaT cells at a concentration of 0-40 μg/mL. .
E实时荧光定量PCRE real-time quantitative PCR
使用RNeasy迷你试剂盒(Qiagen,Pudong,Shanghai,China)从经40μg/mL防晒抗光老化中药组合物预处理和UVB诱导过的HaCaT细胞中提取RNA,然后使用GoScript逆转录混合物(Promega,WI)逆转录每个样品500ng RNA。然后将EVA Green Supermix(Bio-Rad,CA)用于实时定量PCR,β-actin用作内参。MMP1、I型胶原和TIMP1的引物用Primer5设计,如表1所示。2-ΔCt方法用于量化相对基因表达。RNA was extracted from HaCaT cells pretreated with 40 μg/mL sunscreen and anti-photoaging TCM composition and induced by UVB using the RNeasy mini kit (Qiagen, Pudong, Shanghai, China), followed by GoScript reverse transcription cocktail (Promega, WI) 500ng RNA per sample was reverse transcribed. EVA Green Supermix (Bio-Rad, CA) was then used for real-time quantitative PCR and β-actin was used as an internal control. Primers for MMP1, collagen type I and TIMP1 were designed with Primer5 as shown in Table 1. The 2 -ΔCt method was used to quantify relative gene expression.
表1Table 1
结果如图5所示,40μg/mL的防晒抗光老化中药组合物能够部分逆转HaCaT细胞因UVB诱导导致的I型胶原蛋白和TIMP1的mRNA表达下降以及MMP1的mRNA表达上调。The results are shown in Figure 5. The 40 μg/mL sunscreen and anti-photoaging traditional Chinese medicine composition can partially reverse the decrease in the mRNA expression of type I collagen and TIMP1 and the up-regulation of the mRNA expression of MMP1 in HaCaT cells induced by UVB.
F红细胞溶血实验F red blood cell hemolysis test
健康家兔心脏取血7mL,加2%草酸钾溶液1mL,制备成新鲜抗凝兔血,加PBS10mL稀释,4℃冰箱保存备用。配制样品系列溶液。每种样品均设立8个试验剂量必须保证各稀释样品悬液充分混匀。溶血及蛋白变性测定:样品组每个浓度2支具塞试管,每管加入样品悬液10mL;阴性对照组2支具塞试管,每管加入PBS10mL;阳性对照组2支具塞试管,每管加入蒸馏水10mL。每支试管加入0.2mL稀释兔血,轻轻混匀,37C孵育30min。结束后,离心10min,2000rmin,吸取上清液移入比色皿内,于分光光度计540nm,560nm及575nm测其吸光度(A)值。按公式①计算溶血率(%),公式②计算血红蛋白变性指数(D I,%)。其中R1为空白对照蒸馏水的离心上清液A575/A540值;R2为样品离心上清液A575/A540值;R3为阳性对照SDS离心上清液A575/A540值。主要观察指标为50%红细胞发生溶血时的样品浓度(HD50)、蛋白质变性指数(DI)、HD50与变性指数DI的比值(IP=HD50/D I)。7 mL of blood was collected from the heart of healthy rabbits, and 1 mL of 2% potassium oxalate solution was added to prepare fresh anticoagulated rabbit blood, diluted with 10 mL of PBS, and stored in a refrigerator at 4°C for later use. Prepare sample series solutions. 8 test doses are set up for each sample, and it must be ensured that the diluted sample suspensions are thoroughly mixed. Determination of hemolysis and protein denaturation: the sample group has 2 test tubes with stoppers for each concentration, and each tube is filled with 10 mL of sample suspension; the negative control group has 2 test tubes with stoppers, and each tube is added with 10 mL of PBS; the positive control group has 2 test tubes with stoppers, each tube is filled with
结果如图6所示,防晒抗光老化中药组合物浓度在100μg/mL以下呈不溶血。The results are shown in Figure 6, the concentration of the sunscreen and anti-photoaging traditional Chinese medicine composition is insoluble in hemolysis below 100 μg/mL.
以上所述,仅为本发明的较佳实施例而已,故不能依此限定本发明实施的范围,即依本发明专利范围及说明书内容所作的等效变化与修饰,皆应仍属本发明涵盖的范围内。The above are only the preferred embodiments of the present invention, so the scope of implementation of the present invention cannot be limited accordingly, that is, equivalent changes and modifications made according to the patent scope of the present invention and the contents of the description should still be covered by the present invention. In the range.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210649612.8A CN114948816A (en) | 2022-06-09 | 2022-06-09 | A kind of sunscreen and anti-photoaging traditional Chinese medicine composition and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210649612.8A CN114948816A (en) | 2022-06-09 | 2022-06-09 | A kind of sunscreen and anti-photoaging traditional Chinese medicine composition and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114948816A true CN114948816A (en) | 2022-08-30 |
Family
ID=82960896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210649612.8A Pending CN114948816A (en) | 2022-06-09 | 2022-06-09 | A kind of sunscreen and anti-photoaging traditional Chinese medicine composition and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114948816A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393567A (en) * | 2013-07-29 | 2013-11-20 | 嘉文丽(福建)化妆品有限公司 | Anti-acne cosmetics containing Taiwan mountain hibiscus extract |
| CN107949370A (en) * | 2015-09-09 | 2018-04-20 | 皮埃尔法布雷医药公司 | For making the capejasmine extract of pigmenting of skin |
| CN108354859A (en) * | 2018-04-28 | 2018-08-03 | 云南省药物研究所 | A kind of preparation method of the anti-acne chemical product of the extract containing trilliaceae and application |
| CN112076126A (en) * | 2020-09-28 | 2020-12-15 | 嘉文丽(福建)化妆品有限公司 | Separation method of whitening functional components in hibiscus mutabilis and application of whitening functional components in cosmetics |
| CN114588225A (en) * | 2021-12-20 | 2022-06-07 | 嘉文丽(福建)化妆品有限公司 | Method for extracting and converting saponin in Trillium fortunei |
-
2022
- 2022-06-09 CN CN202210649612.8A patent/CN114948816A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393567A (en) * | 2013-07-29 | 2013-11-20 | 嘉文丽(福建)化妆品有限公司 | Anti-acne cosmetics containing Taiwan mountain hibiscus extract |
| CN107949370A (en) * | 2015-09-09 | 2018-04-20 | 皮埃尔法布雷医药公司 | For making the capejasmine extract of pigmenting of skin |
| CN108354859A (en) * | 2018-04-28 | 2018-08-03 | 云南省药物研究所 | A kind of preparation method of the anti-acne chemical product of the extract containing trilliaceae and application |
| CN112076126A (en) * | 2020-09-28 | 2020-12-15 | 嘉文丽(福建)化妆品有限公司 | Separation method of whitening functional components in hibiscus mutabilis and application of whitening functional components in cosmetics |
| CN114588225A (en) * | 2021-12-20 | 2022-06-07 | 嘉文丽(福建)化妆品有限公司 | Method for extracting and converting saponin in Trillium fortunei |
Non-Patent Citations (1)
| Title |
|---|
| 国家食品药品监督管理总局: "《化妆品安全技术规范》", pages: 35 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105816702A (en) | Sugarcane polyphenols extract and preparation method and application thereof | |
| CN105147588A (en) | Ginseng fermentation puree as well as preparation method and application thereof | |
| CN119367225A (en) | Human albumin anti-aging essence and preparation method thereof | |
| CN117257685B (en) | An oil-soluble anti-wrinkle composition and its extraction method | |
| CN118078698A (en) | Tricholoma matsutake extract with effects of relieving and delaying aging, and preparation method and application thereof | |
| CN102675468A (en) | A kind of earthworm extract and its extraction method and application | |
| CN104983915A (en) | Preparation method of natural lycium ruthenicum composite antioxidant | |
| CN114948816A (en) | A kind of sunscreen and anti-photoaging traditional Chinese medicine composition and application thereof | |
| CN112933018B (en) | Composition with barrier repairing and anti-photoaging effects and preparation method and application thereof | |
| CN110859867B (en) | Method for extracting total flavonoids of eucommia ulmoides and application of total flavonoids of eucommia ulmoides in antioxidant and hypoglycemic agent | |
| CN118370708A (en) | Preparation method of moonwort extract, product and application thereof | |
| TW202106329A (en) | Viola mandshuricaextract, extraction method thereof, and use thereof for enhancing fibroblast cell proliferation, for enhancing mitochondrial activity, and for increasing skin luster | |
| CN114848566B (en) | Preparation method and application of dendrobium officinale extract for resisting skin photoaging | |
| CN113952264B (en) | Application of lycium ruthenicum extract in preparation of skin care product and skin care product | |
| CN117503658A (en) | Multi-effect composition containing recombinant collagen and preparation method and application thereof | |
| CN107028823A (en) | One kind prepares high security, and microbial fermentation processes of radix glycyrrhizae zymotic fluid with whitening and anti-aging effects and products thereof | |
| CN106265175A (en) | Rhizoma Fagopyri Dibotryis extract, preparation method, apply and containing its skin preparations for extenal use | |
| CN110897957B (en) | Plant extract composition, preparation method and application thereof in cosmetics | |
| CN117898984A (en) | Preparation method of tea fermentation product with anti-aging effect for cosmetics | |
| CN115554207A (en) | Plant composition and preparation method thereof | |
| CN113813311A (en) | Lycium ruthenicum extract and preparation method and application thereof | |
| CN116159089A (en) | Phenethyl alcohol glycoside extract, preparation method thereof and application thereof in anti-saccharification | |
| CN115746166B (en) | A kind of betel leaf pectin and its preparation method and application | |
| CN111840350A (en) | Artemisia selengensis alcohol extract with anti-inflammatory effect and preparation method and application thereof | |
| CN118370789B (en) | Traditional Chinese medicine composition for repairing cell injury and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220830 |